Gene · 3357
Papers2,210
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,210
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impact of specific serotonin receptor modulation on restricted repetitive behaviors. | Front Behav Neurosci | 2022 | 36620862 | PubTator, text mining | PubMed |
| Neutrophil dynamics and inflammaging in acute ischemic stroke: A transcriptomic review. | Front Aging Neurosci | 2022 | 36620775 | PubTator, text mining | PubMed |
| Recent advances in understanding adverse effects associated with drugs targeting the serotonin receptor, 5-HT GPCR. | Front Glob Womens Health | 2022 | 36619589 | PubTator, text mining | PubMed |
| Elucidating the mechanism of Hongjinshen decoction in the treatment of pulmonary fibrosis based on network pharmacology and molecular docking. | Medicine (Baltimore) | 2022 | 36595795 | PubTator, text mining | PubMed |
| Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11. | Front Psychiatry | 2022 | 36590635 | PubTator, text mining | PubMed |
| The connection between innervation and metabolic rearrangements in pancreatic cancer through serine. | Front Oncol | 2022 | 36582785 | PubTator, text mining | PubMed |
| Riddle of the Sphinx: facts and evidence regarding the link between mental stress and tumor occurrence and development. | Chin Med J (Engl) | 2022 | 36580651 | PubTator, text mining | PubMed |
| Potential bioactive compounds and mechanisms of Fibraurea recisa Pierre for the treatment of Alzheimer's disease analyzed by network pharmacology and molecular docking prediction. | Front Aging Neurosci | 2022 | 36570530 | PubTator, text mining | PubMed |
| Cryo-EM structure of the human adenosine A2B receptor-Gs signaling complex. | Sci Adv | 2022 | 36563137 | PubTator, text mining | PubMed |
| Dynamics and Patterning of 5-Hydroxytryptamine 2 Subtype Receptors in JC Polyomavirus Entry. | Viruses | 2022 | 36560603 | PubTator, text mining | PubMed |
| 4-Isobutylmethcathinone-A Novel Synthetic Cathinone with High In Vitro Cytotoxicity and Strong Receptor Binding Preference of Enantiomers. | Pharmaceuticals (Basel) | 2022 | 36558946 | PubTator, text mining | PubMed |
| A Review: Meridianins and Meridianins Derivatives. | Molecules | 2022 | 36557848 | PubTator, text mining | PubMed |
| Association between Genotype, Presentation, and Outcome in Childhood Idiopathic and Hereditary Pulmonary Arterial Hypertension. | J Clin Med | 2022 | 36555947 | PubTator, text mining | PubMed |
| Key Characteristics and Development of Psychoceuticals: A Review. | Int J Mol Sci | 2022 | 36555419 | PubTator, text mining | PubMed |
| Interplay between Serotonin, Immune Response, and Intestinal Dysbiosis in Inflammatory Bowel Disease. | Int J Mol Sci | 2022 | 36555276 | PubTator, text mining | PubMed |
| The Metastatic Process through the Eyes of Epigenetic Regulation: A Promising Horizon for Cancer Therapy. | Int J Mol Sci | 2022 | 36555088 | PubTator, text mining | PubMed |
| Seventy Years of Treating Delusional Disorder with Antipsychotics: A Historical Perspective. | Biomedicines | 2022 | 36552037 | PubTator, text mining | PubMed |
| Serotonin system in the human placenta - the knowns and unknowns. | Front Endocrinol (Lausanne) | 2022 | 36531448 | PubTator, text mining | PubMed |
| Third-generation antipsychotics in patients with schizophrenia and non-responsivity or intolerance to clozapine regimen: What is the evidence? | Front Psychiatry | 2022 | 36523870 | PubTator, text mining | PubMed |
| Polycystic ovary syndrome: Identification of novel and hub biomarkers in the autophagy-associated mRNA-miRNA-lncRNA network. | Front Endocrinol (Lausanne) | 2022 | 36523600 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3357/papers?page=18